argenx
3 known investors
argenx is an immunology company that operates an antibody innovation ecosystem where scientists and antibody engineers develop novel targets, disease pathways, and therapeutic antibodies. It builds a proprietary portfolio of first-in-class product candidates, engineered with academic partners, to translate immunology research into medicines for patients.
BiotechHealthtech
Investors · 3
Frequently asked questions
- What does argenx do?
- argenx is an immunology company that operates an antibody innovation ecosystem where scientists and antibody engineers develop novel targets, disease pathways, and therapeutic antibodies. It builds a proprietary portfolio of first-in-class product candidates, engineered with academic partners, to translate immunology research into medicines for patients.
- Who are argenx's investors?
- argenx's investors include Avoro Capital Advisors, MPM BioImpact, PMV.